Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Huang

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Clinical and Diagnostic Laboratory Immunology|March 12, 2004
Antibody response of healthy adults to recombinant thrombospondin-related adhesive protein of cryptosporidium 1 after experimental exposure to cryptosporidium oocystsPablo C Okhuysen, G Aaron Rogers, Andrea Crisanti, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2019
<i>In Vitro</i> Activities of β-Lactam-β-Lactamase Inhibitor Antimicrobial Agents against Cystic Fibrosis Respiratory PathogensLindsay J Caverly, Theodore Spilker, Linda M Kalikin, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|February 22, 2011
Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospitalEric Gomez, Carl Urban, Noriel Mariano, et al.
Journal of Medical Microbiology|September 26, 2007
Virulence characteristics and the molecular epidemiology of enteroaggregative Escherichia coli isolates from travellers to developing countriesDavid B Huang, Jamal A Mohamed, James P Nataro, et al.
Journal of Global Antimicrobial Resistance|March 4, 2021
In vitro activity of iclaprim and comparator agents against Listeria monocytogenes clinical isolates from 2012 to 2018David B Huang, Leonard R Duncan, Yahse K Edah, et al.
BMC Infectious Diseases|June 8, 2013
A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumoniaAndrew F Shorr, Daniela E Myers, David B Huang, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2022
A Phase 1 Study To Evaluate Safety and Pharmacokinetics following Administration of Single and Multiple Doses of the Antistaphylococcal Lysin LSVT-1701 in Healthy Adult SubjectsMary Beth Wire, Soo Youn Jun, In-Jin Jang, et al.
Journal of Clinical Pharmacology|August 14, 2010
Coadministration with lopinavir and ritonavir decreases exposure to BILR 355, a nonnucleoside reverse transcriptase inhibitor, in healthy volunteersFenglei Huang, Paul Scholl, David B Huang, et al.
Case Reports in Medicine|December 14, 2011
Polymyxin Combination Therapy and the Use of Serum Bactericidal Titers in the Management of KPC-Producing Klebsiella pneumoniae Infections: A Report of 3 CasesEric Gomez, Martha Sanchez, Zonaira Gul, et al.
Basic & Clinical Pharmacology & Toxicology|October 28, 2010
Concomitant administration of BILR 355/r with emtricitabine/tenofovir disoproxil fumarate increases exposure to emtricitabine and tenofovir: a randomized, open-label, prospective studyFenglei Huang, Paul Scholl, David B Huang, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Clinical and Diagnostic Laboratory Immunology|March 12, 2004
Antibody response of healthy adults to recombinant thrombospondin-related adhesive protein of cryptosporidium 1 after experimental exposure to cryptosporidium oocystsPablo C Okhuysen, G Aaron Rogers, Andrea Crisanti, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2019
<i>In Vitro</i> Activities of β-Lactam-β-Lactamase Inhibitor Antimicrobial Agents against Cystic Fibrosis Respiratory PathogensLindsay J Caverly, Theodore Spilker, Linda M Kalikin, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|February 22, 2011
Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospitalEric Gomez, Carl Urban, Noriel Mariano, et al.
Journal of Medical Microbiology|September 26, 2007
Virulence characteristics and the molecular epidemiology of enteroaggregative Escherichia coli isolates from travellers to developing countriesDavid B Huang, Jamal A Mohamed, James P Nataro, et al.
Journal of Global Antimicrobial Resistance|March 4, 2021
In vitro activity of iclaprim and comparator agents against Listeria monocytogenes clinical isolates from 2012 to 2018David B Huang, Leonard R Duncan, Yahse K Edah, et al.
BMC Infectious Diseases|June 8, 2013
A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumoniaAndrew F Shorr, Daniela E Myers, David B Huang, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2022
A Phase 1 Study To Evaluate Safety and Pharmacokinetics following Administration of Single and Multiple Doses of the Antistaphylococcal Lysin LSVT-1701 in Healthy Adult SubjectsMary Beth Wire, Soo Youn Jun, In-Jin Jang, et al.
Journal of Clinical Pharmacology|August 14, 2010
Coadministration with lopinavir and ritonavir decreases exposure to BILR 355, a nonnucleoside reverse transcriptase inhibitor, in healthy volunteersFenglei Huang, Paul Scholl, David B Huang, et al.
Case Reports in Medicine|December 14, 2011
Polymyxin Combination Therapy and the Use of Serum Bactericidal Titers in the Management of KPC-Producing Klebsiella pneumoniae Infections: A Report of 3 CasesEric Gomez, Martha Sanchez, Zonaira Gul, et al.
Basic & Clinical Pharmacology & Toxicology|October 28, 2010
Concomitant administration of BILR 355/r with emtricitabine/tenofovir disoproxil fumarate increases exposure to emtricitabine and tenofovir: a randomized, open-label, prospective studyFenglei Huang, Paul Scholl, David B Huang, et al.
Pageof 9